Journal
CLINICS IN LIVER DISEASE
Volume 15, Issue 2, Pages 297-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cld.2011.03.012
Keywords
Hepatocellular carcinoma; Cirrhosis; alpha-Fetoprotein; Des-gamma-carboxyprothrombin; Glypican-3; Immunohistochemistry; Proteomics
Categories
Ask authors/readers for more resources
Early diagnosis of hepatocellular carcinoma (HCC) has a significant impact on survival by implementation of effective treatment strategies, including hepatic resection, locoregional ablative therapy, and liver transplantation. The use of serum tumor markers and biopsy are particularly important for diagnosis of small hepatic lesions with atypical features on imaging studies. a-Fetoprotein remains the most frequently used tumor marker for the diagnosis of HCC. The development of novel serum biomarkers for HOC, identification of molecular markers for tissue immunohistochemistry, and emergence of new diagnostic techniques such as proteomic profiling may improve the early detection rate of HOC in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available